179 filings
6-K
EVAX
Evaxion Biotech A/S
27 Mar 24
Evaxion Announces Business Update and Full Year 2023 Financial Results
8:30am
20-F
2023 FY
EVAX
Evaxion Biotech A/S
Annual report (foreign)
26 Mar 24
4:01pm
6-K
EVAX
Evaxion Biotech A/S
19 Mar 24
Evaxion Hosts R&D Day and Unveils the Broad Potential of Its AI-Immunology™ Platform
8:17am
6-K
EVAX
Evaxion Biotech A/S
13 Mar 24
Current report (foreign)
4:30pm
6-K
EVAX
Evaxion Biotech A/S
29 Feb 24
Current report (foreign)
7:35am
6-K
EVAX
Evaxion Biotech A/S
20 Feb 24
Evaxion Announces Successful Completion of the Initial Phases of Ongoing Vaccine Collaboration with MSD
7:32am
6-K
EVAX
Evaxion Biotech A/S
7 Feb 24
Current report (foreign)
4:30pm
6-K
EVAX
Evaxion Biotech A/S
7 Feb 24
Current report (foreign)
8:30am
6-K
EVAX
Evaxion Biotech A/S
6 Feb 24
Evaxion Announces Closing of $15 Million Public Offering
8:30am
424B4
EVAX
Evaxion Biotech A/S
5 Feb 24
Prospectus supplement with pricing info
9:09am
6-K
EVAX
Evaxion Biotech A/S
5 Feb 24
Securities Purchase Agreement
7:00am
EFFECT
EVAX
Evaxion Biotech A/S
2 Feb 24
Notice of effectiveness
12:15am
6-K
EVAX
Evaxion Biotech A/S
1 Feb 24
Evaxion Biotech Announces Pricing of $15 Million Public Offering
9:20am
F-1/A
EVAX
Evaxion Biotech A/S
31 Jan 24
Registration statement (foreign) (amended)
5:10pm
F-1/A
EVAX
Evaxion Biotech A/S
31 Jan 24
Registration statement (foreign) (amended)
9:26am
F-1/A
EVAX
Evaxion Biotech A/S
30 Jan 24
Registration statement (foreign) (amended)
3:16pm
CORRESP
EVAX
Evaxion Biotech A/S
30 Jan 24
Correspondence with SEC
12:00am
6-K
EVAX
Evaxion Biotech A/S
26 Jan 24
Current report (foreign)
4:30pm
6-K
EVAX
Evaxion Biotech A/S
24 Jan 24
Evaxion to Develop Tailored Novel Cancer Vaccines Based upon a New Untapped Source of AI-Discovered Targets
2:11pm
SC 13G
EVAX
Evaxion Biotech A/S
23 Jan 24
Evaxion Biotech A/S / Merck & Co. ownership change
3:29pm